SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences informs about receipt of order

16 Sep 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that it has been awarded a contract by a reputed client based in Europe. The total value of the contract is $200,000. The contract is related to Contract development and manufacturing organization (CDMO) and is expected to contribute significantly to the company’s revenue for the current financial year. This is for your information and records. Kindly take the same on record.

The above information is a part of company’s filings submitted to BSE.


Kimia Biosciences Share Price

37.97 0.29 (0.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×